Cargando…

260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis

OBJECTIVES/GOALS: In this study, the ability of a pathologist to detect malignancy on digital pseudo-H&E slides obtained via structured illumination microscopy (SIM) imaging of fresh diagnostic breast biopsies was assessed. The speed of imaging and processing was also assessed for potential clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Behr, Madeline, Roberts, Brett, Alizadeh, Layla, Brown, J. Quincy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129547/
http://dx.doi.org/10.1017/cts.2023.322
_version_ 1785030766750597120
author Behr, Madeline
Roberts, Brett
Alizadeh, Layla
Brown, J. Quincy
author_facet Behr, Madeline
Roberts, Brett
Alizadeh, Layla
Brown, J. Quincy
author_sort Behr, Madeline
collection PubMed
description OBJECTIVES/GOALS: In this study, the ability of a pathologist to detect malignancy on digital pseudo-H&E slides obtained via structured illumination microscopy (SIM) imaging of fresh diagnostic breast biopsies was assessed. The speed of imaging and processing was also assessed for potential clinical implementation. METHODS/STUDY POPULATION: This study was conducted in accordance with an Ochsner Medical Center of New Orleans IRB. 200 patients undergoing either stereotactic or ultrasound-guided diagnostic breast biopsies were consented and an additional core from the suspicious lesion was collected for research use. Research biopsies were transported to the lab and stained with DRAQ5 and Eosin-Y and imaged with SIM before being submitted for histology processing. Imaging and digital processing times were recorded. The resulting SIM images and histology slides were given to a pathologist for blind review to assess accuracy. RESULTS/ANTICIPATED RESULTS: The ex-vivo structured illumination microscopy images and subsequent histology slides from 79 research cores have been assessed to date. Some samples were excluded from the total data set and not included in the final assessment due to technical failures of the imaging protocol. Of the current set, the pathologist has a specificity of 88% and a sensitivity of 65%, as well as an NPV of 88% and a PPV of 65%. Staining time for each biopsy was completed within 3 and a half minutes and imaging at 20x magnification took between 4 and 12 minutes, depending on size and implementation of autofocus to the imaging system. Image processing took approximately 5 minutes per biopsy and is a direct function of biopsy size. DISCUSSION/SIGNIFICANCE: Decreased time between cancer suspicion and treatment will improve the prognosis of breast cancer patients. SIM imaging of fresh breast biopsies could ultimately allow primary and secondary histology to be performed simultaneously and minimize histopathology time, thus allowing clinicians and patients to implement treatment course more quickly.
format Online
Article
Text
id pubmed-10129547
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-101295472023-04-26 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis Behr, Madeline Roberts, Brett Alizadeh, Layla Brown, J. Quincy J Clin Transl Sci Precision Medicine/Health OBJECTIVES/GOALS: In this study, the ability of a pathologist to detect malignancy on digital pseudo-H&E slides obtained via structured illumination microscopy (SIM) imaging of fresh diagnostic breast biopsies was assessed. The speed of imaging and processing was also assessed for potential clinical implementation. METHODS/STUDY POPULATION: This study was conducted in accordance with an Ochsner Medical Center of New Orleans IRB. 200 patients undergoing either stereotactic or ultrasound-guided diagnostic breast biopsies were consented and an additional core from the suspicious lesion was collected for research use. Research biopsies were transported to the lab and stained with DRAQ5 and Eosin-Y and imaged with SIM before being submitted for histology processing. Imaging and digital processing times were recorded. The resulting SIM images and histology slides were given to a pathologist for blind review to assess accuracy. RESULTS/ANTICIPATED RESULTS: The ex-vivo structured illumination microscopy images and subsequent histology slides from 79 research cores have been assessed to date. Some samples were excluded from the total data set and not included in the final assessment due to technical failures of the imaging protocol. Of the current set, the pathologist has a specificity of 88% and a sensitivity of 65%, as well as an NPV of 88% and a PPV of 65%. Staining time for each biopsy was completed within 3 and a half minutes and imaging at 20x magnification took between 4 and 12 minutes, depending on size and implementation of autofocus to the imaging system. Image processing took approximately 5 minutes per biopsy and is a direct function of biopsy size. DISCUSSION/SIGNIFICANCE: Decreased time between cancer suspicion and treatment will improve the prognosis of breast cancer patients. SIM imaging of fresh breast biopsies could ultimately allow primary and secondary histology to be performed simultaneously and minimize histopathology time, thus allowing clinicians and patients to implement treatment course more quickly. Cambridge University Press 2023-04-24 /pmc/articles/PMC10129547/ http://dx.doi.org/10.1017/cts.2023.322 Text en © The Association for Clinical and Translational Science 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Precision Medicine/Health
Behr, Madeline
Roberts, Brett
Alizadeh, Layla
Brown, J. Quincy
260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis
title 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis
title_full 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis
title_fullStr 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis
title_full_unstemmed 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis
title_short 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis
title_sort 260 breast cancer biopsy triage with ex-vivo microscopy for downstream analysis
topic Precision Medicine/Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129547/
http://dx.doi.org/10.1017/cts.2023.322
work_keys_str_mv AT behrmadeline 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis
AT robertsbrett 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis
AT alizadehlayla 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis
AT brownjquincy 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis